Advancing COPD management through novel pharmacological agents: ensifentrine and dupilumab. - Walkon LL; Burmeister JR; Nazmifar M; Bohler F; Kochanowska-Karamyan A; Allen SA (Breathe (Sheffield, England), 2025)